Stockreport

Opus Genetics to Participate in Leading Medical Conferences in May 2026 [Yahoo! Finance]

Opus Genetics, Inc.  (IRD) 
PDF the “Company”), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients with inherited retinal diseases [Read more]